Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2013, July) Reactions Weekly Vol. 1461 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2013 (July)Volume1461
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13304433Long-form Identifiermindat:1:5:13304433:3
GUID0
Full Reference(2013, July) Reactions Weekly Vol. 1461 (1) Springer Science and Business Media LLC
Plain Text(2013, July) Reactions Weekly Vol. 1461 (1) Springer Science and Business Media LLC
In(2013) Reactions Weekly Vol. 1461. Springer Science and Business Media LLC

Contains

(2013) Antipsychotics differ substantially in terms of tolerability. Reactions Weekly, 1461 (1) 1 doi:10.1007/s40278-013-4519-2
(2013) Canadian study supports early invasive management of ACS. Reactions Weekly, 1461 (1) 2 doi:10.1007/s40278-013-4520-9
(2013) Painkiller overdose deaths increase among women. Reactions Weekly, 1461 (1) 2 doi:10.1007/s40278-013-4521-8
(2013) Use of stimulants for ADHD and subsequent substance abuse. Reactions Weekly, 1461 (1) 2 doi:10.1007/s40278-013-4522-7
(2013) Debate continues over safety of incretin mimetics. Reactions Weekly, 1461 (1) 3 doi:10.1007/s40278-013-4523-6
(2013) Olmesartan label to warn of sprue-like side effects. Reactions Weekly, 1461 (1) 4 doi:10.1007/s40278-013-4524-5
(2013) Roche halts antidiabetic's development in phase III. Reactions Weekly, 1461 (1) 4 doi:10.1007/s40278-013-4525-4
(2013) PRAC begins new review of HES-containing solutions. Reactions Weekly, 1461 (1) 4 doi:10.1007/s40278-013-4526-3
(2013) Linagliptin labels provide greater warnings of pancreatitis risk. Reactions Weekly, 1461 (1) 4 doi:10.1007/s40278-013-4527-2
(2013) India suspends pioglitazone. Reactions Weekly, 1461 (1) 4 doi:10.1007/s40278-013-4528-1
(2013) Albendazole. Reactions Weekly, 1461 (1) 5 doi:10.1007/s40278-013-4529-0
(2013) Aciclovir/antibacterials/cisplatin/pantoprazole. Reactions Weekly, 1461 (1) 5 doi:10.1007/s40278-013-4530-7
(2013) Aceclofenac/desmopressin. Reactions Weekly, 1461 (1) 5 doi:10.1007/s40278-013-4531-6
(2013) Albendazole withdrawal. Reactions Weekly, 1461 (1) 6 doi:10.1007/s40278-013-4532-5
(2013) Allopurinol. Reactions Weekly, 1461 (1) 6 doi:10.1007/s40278-013-4533-4
(2013) Amiodarone. Reactions Weekly, 1461 (1) 6 doi:10.1007/s40278-013-4534-3
(2013) Aminolevulinic acid. Reactions Weekly, 1461 (1) 6 doi:10.1007/s40278-013-4535-2
(2013) Amlodipine/atorvastatin/clopidogrel interaction. Reactions Weekly, 1461 (1) 7 doi:10.1007/s40278-013-4536-1
(2013) Antibacterials. Reactions Weekly, 1461 (1) 7 doi:10.1007/s40278-013-4537-0
(2013) Amisulpride withdrawal. Reactions Weekly, 1461 (1) 7 doi:10.1007/s40278-013-4538-z
(2013) Amphotericin B liposomal. Reactions Weekly, 1461 (1) 7 doi:10.1007/s40278-013-4539-y
(2013) Antineoplastics. Reactions Weekly, 1461 (1) 8 doi:10.1007/s40278-013-4540-5
(2013) Antihypertensives. Reactions Weekly, 1461 (1) 8 doi:10.1007/s40278-013-4541-4
(2013) Aripiprazole withdrawal. Reactions Weekly, 1461 (1) 8 doi:10.1007/s40278-013-4542-3
(2013) Artesunate/amodiaquine overdose. Reactions Weekly, 1461 (1) 8 doi:10.1007/s40278-013-4543-2
(2013) Antineoplastics. Reactions Weekly, 1461 (1) 8 doi:10.1007/s40278-013-4544-1
(2013) Bevacizumab. Reactions Weekly, 1461 (1) 9 doi:10.1007/s40278-013-4545-0
(2013) Articaine. Reactions Weekly, 1461 (1) 9 doi:10.1007/s40278-013-4546-z
(2013) Azathioprine. Reactions Weekly, 1461 (1) 9 doi:10.1007/s40278-013-4547-y
(2013) Atorvastatin/fenofibrate. Reactions Weekly, 1461 (1) 9 doi:10.1007/s40278-013-4548-x
(2013) Benzatropine/chlorpromazine/haloperidol. Reactions Weekly, 1461 (1) 9 doi:10.1007/s40278-013-4549-9
(2013) Bevacizumab. Reactions Weekly, 1461 (1) 10 doi:10.1007/s40278-013-4550-3
(2013) Bevacizumab. Reactions Weekly, 1461 (1) 10 doi:10.1007/s40278-013-4551-2
(2013) Bevacizumab. Reactions Weekly, 1461 (1) 10 doi:10.1007/s40278-013-4552-1
(2013) Bisphosphonates. Reactions Weekly, 1461 (1) 11 doi:10.1007/s40278-013-4553-0
(2013) Bevacizumab/pazopanib. Reactions Weekly, 1461 (1) 11 doi:10.1007/s40278-013-4554-z
(2013) Brentuximab vedotin. Reactions Weekly, 1461 (1) 11 doi:10.1007/s40278-013-4555-y
(2013) Bevacizumab/interferon-α. Reactions Weekly, 1461 (1) 11 doi:10.1007/s40278-013-4556-x
(2013) Bevacizumab. Reactions Weekly, 1461 (1) 11 doi:10.1007/s40278-013-4557-9
(2013) Buprenorphine. Reactions Weekly, 1461 (1) 12 doi:10.1007/s40278-013-4558-8
(2013) Caspofungin/cytarabine/daunorubicin. Reactions Weekly, 1461 (1) 12 doi:10.1007/s40278-013-4559-7
(2013) Cabozantinib. Reactions Weekly, 1461 (1) 12 doi:10.1007/s40278-013-4560-1
(2013) Chlorhexidine. Reactions Weekly, 1461 (1) 13 doi:10.1007/s40278-013-4561-0
(2013) Charcoal. Reactions Weekly, 1461 (1) 13 doi:10.1007/s40278-013-4562-z
(2013) Chloroquine. Reactions Weekly, 1461 (1) 13 doi:10.1007/s40278-013-4563-y
(2013) Cetuximab. Reactions Weekly, 1461 (1) 13 doi:10.1007/s40278-013-4564-x
(2013) Clozapine. Reactions Weekly, 1461 (1) 14 doi:10.1007/s40278-013-4565-9
(2013) Clopidogrel/warfarin. Reactions Weekly, 1461 (1) 14 doi:10.1007/s40278-013-4566-8
(2013) Clobetasol. Reactions Weekly, 1461 (1) 14 doi:10.1007/s40278-013-4567-7
(2013) Clindamycin/vancomycin. Reactions Weekly, 1461 (1) 14 doi:10.1007/s40278-013-4568-6
(2013) Colchicine/loxoprofen. Reactions Weekly, 1461 (1) 15 doi:10.1007/s40278-013-4569-5
(2013) Clozapine. Reactions Weekly, 1461 (1) 15 doi:10.1007/s40278-013-4570-z
(2013) Clozapine. Reactions Weekly, 1461 (1) 15 doi:10.1007/s40278-013-4571-y
(2013) Clozapine. Reactions Weekly, 1461 (1) 15 doi:10.1007/s40278-013-4572-x
(2013) Cyclophosphamide. Reactions Weekly, 1461 (1) 16 doi:10.1007/s40278-013-4573-9
(2013) Crotalid venoms. Reactions Weekly, 1461 (1) 16 doi:10.1007/s40278-013-4574-8
(2013) Cyclophosphamide/fludarabine. Reactions Weekly, 1461 (1) 16 doi:10.1007/s40278-013-4575-7
(2013) Cyclophosphamide/prednisone. Reactions Weekly, 1461 (1) 17 doi:10.1007/s40278-013-4576-6
(2013) Diclofenac. Reactions Weekly, 1461 (1) 17 doi:10.1007/s40278-013-4577-5
(2013) Dabigatran etexilate. Reactions Weekly, 1461 (1) 17 doi:10.1007/s40278-013-4578-4
(2013) Dabigatran etexilate. Reactions Weekly, 1461 (1) 17 doi:10.1007/s40278-013-4579-3
(2013) Docetaxel/oxaliplatin/paclitaxel. Reactions Weekly, 1461 (1) 18 doi:10.1007/s40278-013-4580-x
(2013) Diltiazem/furosemide/sildenafil interaction. Reactions Weekly, 1461 (1) 18 doi:10.1007/s40278-013-4581-9
(2013) Ethinylestradiol/cyproterone. Reactions Weekly, 1461 (1) 18 doi:10.1007/s40278-013-4582-8
(2013) Enoxaparin sodium. Reactions Weekly, 1461 (1) 18 doi:10.1007/s40278-013-4583-7
(2013) Erlotinib. Reactions Weekly, 1461 (1) 18 doi:10.1007/s40278-013-4584-6
(2013) Fluorouracil/folinic acid/irinotecan/oxaliplatin. Reactions Weekly, 1461 (1) 19 doi:10.1007/s40278-013-4585-5
(2013) Etonogestrel. Reactions Weekly, 1461 (1) 19 doi:10.1007/s40278-013-4586-4
(2013) Fenofibrate. Reactions Weekly, 1461 (1) 19 doi:10.1007/s40278-013-4587-3
(2013) Etonogestrel. Reactions Weekly, 1461 (1) 19 doi:10.1007/s40278-013-4588-2
(2013) Fluoxetine/quinine. Reactions Weekly, 1461 (1) 20 doi:10.1007/s40278-013-4589-1
(2013) Furosemide. Reactions Weekly, 1461 (1) 20 doi:10.1007/s40278-013-4590-8
(2013) Harpagoside/valsartan interaction. Reactions Weekly, 1461 (1) 20 doi:10.1007/s40278-013-4591-7
(2013) Heparin. Reactions Weekly, 1461 (1) 21 doi:10.1007/s40278-013-4592-6
(2013) Helichrysum. Reactions Weekly, 1461 (1) 21 doi:10.1007/s40278-013-4593-5
(2013) Hydroxycarbamide. Reactions Weekly, 1461 (1) 21 doi:10.1007/s40278-013-4594-4
(2013) Heparin. Reactions Weekly, 1461 (1) 21 doi:10.1007/s40278-013-4595-3
(2013) Ifosfamide. Reactions Weekly, 1461 (1) 22 doi:10.1007/s40278-013-4596-2
(2013) Ibuprofen/muscle relaxants/valdecoxib. Reactions Weekly, 1461 (1) 22 doi:10.1007/s40278-013-4597-1
(2013) Ibuprofen/lisinopril/metformin. Reactions Weekly, 1461 (1) 22 doi:10.1007/s40278-013-4598-0
(2013) Ibuprofen. Reactions Weekly, 1461 (1) 22 doi:10.1007/s40278-013-4599-z
(2013) Imatinib. Reactions Weekly, 1461 (1) 23 doi:10.1007/s40278-013-4600-x
(2013) Imatinib. Reactions Weekly, 1461 (1) 23 doi:10.1007/s40278-013-4601-9
(2013) Ifosfamide/warfarin. Reactions Weekly, 1461 (1) 23 doi:10.1007/s40278-013-4602-8
(2013) Imatinib. Reactions Weekly, 1461 (1) 23 doi:10.1007/s40278-013-4603-7
(2013) Immunosuppressants. Reactions Weekly, 1461 (1) 24 doi:10.1007/s40278-013-4604-6
(2013) Imiquimod. Reactions Weekly, 1461 (1) 24 doi:10.1007/s40278-013-4605-5
(2013) Immunomodulators. Reactions Weekly, 1461 (1) 24 doi:10.1007/s40278-013-4606-4
(2013) Immune globulin. Reactions Weekly, 1461 (1) 24 doi:10.1007/s40278-013-4607-3
(2013) Insulin glargine overdose. Reactions Weekly, 1461 (1) 25 doi:10.1007/s40278-013-4608-2
(2013) Isoflurane. Reactions Weekly, 1461 (1) 25 doi:10.1007/s40278-013-4609-1
(2013) Indacaterol. Reactions Weekly, 1461 (1) 25 doi:10.1007/s40278-013-4610-8
(2013) Infliximab. Reactions Weekly, 1461 (1) 25 doi:10.1007/s40278-013-4611-7
(2013) Iron. Reactions Weekly, 1461 (1) 25 doi:10.1007/s40278-013-4612-6
(2013) Lamotrigine/sodium valproate interaction. Reactions Weekly, 1461 (1) 26 doi:10.1007/s40278-013-4613-5
(2013) Isoniazid. Reactions Weekly, 1461 (1) 26 doi:10.1007/s40278-013-4614-4
(2013) Isoflurane. Reactions Weekly, 1461 (1) 26 doi:10.1007/s40278-013-4615-3
(2013) Lacosamide. Reactions Weekly, 1461 (1) 26 doi:10.1007/s40278-013-4616-2
(2013) Levofloxacin. Reactions Weekly, 1461 (1) 27 doi:10.1007/s40278-013-4617-1
(2013) Lidocaine. Reactions Weekly, 1461 (1) 27 doi:10.1007/s40278-013-4618-0
(2013) Levothyroxine sodium overdose. Reactions Weekly, 1461 (1) 27 doi:10.1007/s40278-013-4619-z
(2013) Lenalidomide. Reactions Weekly, 1461 (1) 27 doi:10.1007/s40278-013-4620-6
(2013) Levodopa. Reactions Weekly, 1461 (1) 27 doi:10.1007/s40278-013-4621-5
(2013) Lisinopril. Reactions Weekly, 1461 (1) 28 doi:10.1007/s40278-013-4622-4
(2013) Magnesium oxide. Reactions Weekly, 1461 (1) 28 doi:10.1007/s40278-013-4623-3
(2013) Metformin overdose. Reactions Weekly, 1461 (1) 28 doi:10.1007/s40278-013-4624-2
(2013) Mesalazine. Reactions Weekly, 1461 (1) 28 doi:10.1007/s40278-013-4625-1
(2013) Methotrexate. Reactions Weekly, 1461 (1) 29 doi:10.1007/s40278-013-4626-0
(2013) Methotrexate. Reactions Weekly, 1461 (1) 29 doi:10.1007/s40278-013-4627-z
(2013) Methylprednisolone/mycophenolate mofetil/tacrolimus. Reactions Weekly, 1461 (1) 29 doi:10.1007/s40278-013-4628-y
(2013) Methotrexate. Reactions Weekly, 1461 (1) 29 doi:10.1007/s40278-013-4629-x
(2013) Mycophenolate mofetil. Reactions Weekly, 1461 (1) 30 doi:10.1007/s40278-013-4630-4
(2013) Minocycline. Reactions Weekly, 1461 (1) 30 doi:10.1007/s40278-013-4631-3
(2013) Misoprostol. Reactions Weekly, 1461 (1) 30 doi:10.1007/s40278-013-4632-2
(2013) Multiple drugs. Reactions Weekly, 1461 (1) 30 doi:10.1007/s40278-013-4633-1
(2013) Multiple drugs. Reactions Weekly, 1461 (1) 30 doi:10.1007/s40278-013-4634-0
(2013) Olanzapine. Reactions Weekly, 1461 (1) 31 doi:10.1007/s40278-013-4636-y
(2013) Naftidrofuryl oxalate overdose. Reactions Weekly, 1461 (1) 31 doi:10.1007/s40278-013-4637-x
(2013) Naproxen sodium. Reactions Weekly, 1461 (1) 31 doi:10.1007/s40278-013-4638-9
(2013) Nitrofurantoin. Reactions Weekly, 1461 (1) 31 doi:10.1007/s40278-013-4635-z
(2013) Prednisolone/rituximab. Reactions Weekly, 1461 (1) 32 doi:10.1007/s40278-013-4639-8
(2013) Propranolol. Reactions Weekly, 1461 (1) 32 doi:10.1007/s40278-013-4640-2
(2013) Olanzapine. Reactions Weekly, 1461 (1) 32 doi:10.1007/s40278-013-4641-1
(2013) Pazopanib. Reactions Weekly, 1461 (1) 32 doi:10.1007/s40278-013-4642-0
(2013) Quetiapine overdose. Reactions Weekly, 1461 (1) 32 doi:10.1007/s40278-013-4643-z
(2013) Rifampicin overdose. Reactions Weekly, 1461 (1) 33 doi:10.1007/s40278-013-4644-y
(2013) Rotavirus W179-9 vaccine. Reactions Weekly, 1461 (1) 33 doi:10.1007/s40278-013-4645-x
(2013) Sirolimus. Reactions Weekly, 1461 (1) 33 doi:10.1007/s40278-013-4646-9
(2013) Rituximab. Reactions Weekly, 1461 (1) 33 doi:10.1007/s40278-013-4647-8
(2013) Rifampicin. Reactions Weekly, 1461 (1) 33 doi:10.1007/s40278-013-4648-7
(2013) Sorafenib/vinflunine. Reactions Weekly, 1461 (1) 34 doi:10.1007/s40278-013-4649-6
(2013) Suxamethonium chloride. Reactions Weekly, 1461 (1) 34 doi:10.1007/s40278-013-4650-0
(2013) Sirolimus. Reactions Weekly, 1461 (1) 34 doi:10.1007/s40278-013-4651-z
(2013) Sorafenib. Reactions Weekly, 1461 (1) 34 doi:10.1007/s40278-013-4652-y
(2013) Topiramate. Reactions Weekly, 1461 (1) 35 doi:10.1007/s40278-013-4653-x
(2013) Triamcinolone. Reactions Weekly, 1461 (1) 35 doi:10.1007/s40278-013-4654-9
(2013) Tamoxifen. Reactions Weekly, 1461 (1) 35 doi:10.1007/s40278-013-4655-8
(2013) Treprostinil. Reactions Weekly, 1461 (1) 35 doi:10.1007/s40278-013-4656-7
(2013) Thiamazole. Reactions Weekly, 1461 (1) 35 doi:10.1007/s40278-013-4657-6
(2013) Tenecteplase. Reactions Weekly, 1461 (1) 35 doi:10.1007/s40278-013-4658-5
(2013) Vancomycin. Reactions Weekly, 1461 (1) 36 doi:10.1007/s40278-013-4659-4
(2013) Valproic acid. Reactions Weekly, 1461 (1) 36 doi:10.1007/s40278-013-4660-y
(2013) Valproic acid. Reactions Weekly, 1461 (1) 36 doi:10.1007/s40278-013-4661-x
(2013) Vemurafenib. Reactions Weekly, 1461 (1) 36 doi:10.1007/s40278-013-4662-9
(2013) Warfarin. Reactions Weekly, 1461 (1) 37 doi:10.1007/s40278-013-4663-8
(2013) Vemurafenib. Reactions Weekly, 1461 (1) 37 doi:10.1007/s40278-013-4664-7
(2013) Vincristine. Reactions Weekly, 1461 (1) 37 doi:10.1007/s40278-013-4665-6
(2013) Voriconazole. Reactions Weekly, 1461 (1) 37 doi:10.1007/s40278-013-4666-5
(2013) Warfarin. Reactions Weekly, 1461 (1) 38 doi:10.1007/s40278-013-4667-4
(2013) Xylometazoline. Reactions Weekly, 1461 (1) 38 doi:10.1007/s40278-013-4668-3
(2013) Zolpidem overdose. Reactions Weekly, 1461 (1) 38 doi:10.1007/s40278-013-4669-2

See Also

These are possibly similar items as determined by title/reference text matching only.

(2013, July) Reactions Weekly Vol. 1459 (1) Springer Science and Business Media LLC
(2013, July) Reactions Weekly Vol. 1460 (1) Springer Science and Business Media LLC
(2013, July) Reactions Weekly Vol. 1462 (1) Springer Science and Business Media LLC
(2016, July) Reactions Weekly Vol. 1608 (1) Springer Science and Business Media LLC
(2016, July) Reactions Weekly Vol. 1609 (1) Springer Science and Business Media LLC
(2016, July) Reactions Weekly Vol. 1610 (1) Springer Science and Business Media LLC
(2016, July) Reactions Weekly Vol. 1611 (1) Springer Science and Business Media LLC
(2016, July) Reactions Weekly Vol. 1612 (1) Springer Science and Business Media LLC
(2003, July) Reactions Weekly Vol. 961 (1) Springer Science and Business Media LLC
(2007, July) Reactions Weekly Vol. 1162 (1) Springer Science and Business Media LLC
(2014, July) Reactions Weekly Vol. 1508 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 15, 2025 10:38:18
Go to top of page